Sandoz to Shutter India API Plant

Source: Hindu Business Line

Jul 17, 2015

Novartis' Sandoz will discontinue operations at its Maharashtra, India site by December 2016, as part of global plans to optimize manufacturing.

The site, located in west-central India, employs 170 people and manufactures antibiotics and APIs.

Sandoz will continue to serve the India market, but will instead focus its manufacturing at its two other, larger sites in India.

Read the Hindu Business Line release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments